Oct 3, 2008 | NEWS
Reykjavik, ICELAND, October 3, 2008 – deCODE genetics (Nasdaq:DCGN) today announced the filing of an investigational new drug (IND) application for DG071, the company’s novel small-molecule modulator of phosphodiesterase 4 (PDE4), with the US Food and Drug...
Sep 14, 2008 | NEWS
Detection may be used to complement and target screening for the disease; variants will be integrated into the deCODEme™ personal genome scan. Reykjavik, ICELAND, September 14, 2008 – Scientists at deCODE genetics (Nasdaq:DCGN) and colleagues at Radboud University...
Aug 17, 2008 | NEWS
A cost-effective method to enable deCODE to extend its leadership in gene discovery to the next challenge in developing market-leading DNA-based diagnostics August 17, 2008 – deCODE has developed a novel analytical method to increase severalfold the amount of...
Jul 30, 2008 | NEWS
Findings may provide the foundation for a test to complement standard clinical diagnosis, potentially enabling earlier intervention and treatment Reykjavik, ICELAND, July 30, 2008 – In a major paper published today in the online edition of the journal Nature,...
Jun 30, 2008 | NEWS
DG041 Blocks Platelet Aggregation Through a Novel Mechanism and does not Increase Bleeding Time When Given Alone or with Plavix™ or Aspirin Reykjavik, ICELAND, June 30, 2008 – deCODE genetics (Nasdaq:DCGN) today announced positive topline results from its latest...
Jun 30, 2008 | NEWS
Reykjavik, ICELAND, June 30, 2008 ― At its annual R&D event being held today in New York, deCODE genetics (Nasdaq:DCGN) will provide an update on progress in all aspects of its business, including the commercial potential and marketing rollout for its growing...
